As you are well aware, the situation with live meetings and events is uncertain for the next several months. Many major meetings have cancelled, postponed, or transitioned. Our current intention is to hold both the Global Myopia Symposium (GMS) and the Global Specialty Lens Symposium (GSLS) live. However, we will probably include an online component for those who cannot or choose not to travel.
Along these lines, the Call for CE Course Submissions for GSLS is live, but coming to a close this Friday, May 15 at 5:00 p.m. Eastern (https://na.eventscloud.com/website /10665/call-for-proposals). As always, we broadly encourage course submissions addressing all aspects of contact lenses, and we hope to see a wide diversity in course topics submitted.
Jason J. Nichols, OD, MPH, PhD
Clerio Launches COVID-19 Program to Financially Boost Independent Eyecare Practitioners
Clerio Vision announced a promotional pricing program to assist independent eyecare practitioners who have been hit hard by the COVID-19 crisis. The company will offer all of its Extreme H2O six-pack products to these professionals for $5 per box. Orders will be shipped directly to patients at no cost. The program begins immediately after sign-up and is running through July 2020. This discount allows practitioners to capture significantly more margin on sales of new fits, according to the company. Clerio has also begun selling N-95 masks and hand sanitizer at its own cost to help Extreme H2O customers to affordably get back up and running.
CooperVision Offers Complimentary Contact Lenses for Hospital Workers
In support of essential hospital workers fighting on the front lines of the COVID-19 pandemic, CooperVision will provide U.S. eyecare professionals with complimentary contact lens refills to extend to these healthcare workers. Through the program, essential hospital workers may receive one box of CooperVision contact lenses for each eye, including all one-day, two-week, and monthly brands that the company manufactures; the workers must be presently working at a hospital in the United States to fight COVID-19. In addition, a current contact lens prescription is required.
The CooperVision Essential Hospital Workers Complimentary Contact Lens Program will run through June 5, 2020. To obtain contact lenses for eligible patients, eyecare professionals must submit an application form via email to CVcares@coopervision.com. Once the application is processed, the lenses will be shipped directly to the address provided for the patient. Orders via authorized distributors will not be accepted for this program. For more information, visit https://coopervision.com/practitioner/ecp-viewpoints/covid-19-resources.
New Digital Phoropter Helps Practitioners Meet Social Distancing Recommendations
Luneau Technology USA announced the expansion of its Visionix product line with the addition of the Visionix VX65 digital phoropter, which is available for sale in the United States and Canada. According to Luneau, the wireless VX65 refraction tablet allows for operation at a safe distance from patients, which could be six feet away, next door, or even from a different office location. Practitioners can choose between “manual phoropter” or “auto-phoropter” modes while controlling the entire refraction process from a hand-held tablet. For those not yet ready for a tablet, an optional ergonomic control panel is also available at an additional cost. The system also allows refraction data to be exported to an electronic medical records (EMR) system with the touch of a button. In addition, data from external devices such as AR/K and lensmeters can be imported to the VX65.
For the most up-to-date COVID-19 news and tips for eyecare providers, visit bit.ly/2WxiFbA.
And, you can now sign up to receive the weekly PentaVision COVID-19 News Roundup newsletter, a joint publication from Contact Lens Spectrum, Eyecare Business, and Optometric Management.
CooperVision Extends Deadline for Science and Technology Awards Proposals
CooperVision has extended the submission deadline for its 2020 Science and Technology Awards program to June 12, with a focus on novel research concepts to address myopia and presbyopia. Over its history, the program has made 14 grants totaling $2 million to investigate matters such as ocular surface health, contact lens discomfort, contact lens functionality, and retinal response to optical defocus.
Proposals may span proof-of-concept through translational stages and are eligible for two types of awards. The CooperVision Seedling Award is intended for investigation of early stage concepts for a one-year period, with a maximum grant of $100,000. The CooperVision Translational Research Award is a two-year grant for substantive projects with funding up to $400,000. It is intended to incentivize collaboration with CooperVision in new research areas.
CooperVision Science and Technology Awards are open to any researcher who has principal investigator (PI) status holding an OD, MD, PhD, or equivalent degree. Applicants such as postdoctoral fellows with a waiver of PI status must submit appropriate documentation before funding can be disbursed.
Santen Pharmaceutical Co., Ltd. announced the introduction of eyedrop bottles made from environmentally friendly biomass plastic materials; biomass plastic refers to plastics produced through chemical or biological synthesis from renewable biomass materials. Because incineration of biomass plastics releases only the carbon derived from the carbon dioxide absorbed through photosynthesis by the plants that make up the contributing biomass, even incinerating such plastics does not lead to an overall increase in carbon dioxide in the atmosphere (a carbon-neutral process). The use of these sustainable resources also plays a role in preventing the exhaustion of fossil fuels, according to the company.
Kala Pharmaceuticals Resubmits New Drug Application for Eysuvis for Dry Eye Disease
Kala Pharmaceuticals, Inc. announced that it has resubmitted its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Eysuvis (loteprednol etabonate ophthalmic suspension) 0.25%, its product candidate for the short-term treatment of the signs and symptoms of dry eye disease. Kala believes that this application will be considered a Class 2 resubmission, with a targeted six-month review timeline under the Prescription Drug User Fee Act (PDUFA). Kala is preparing for a potential U.S. approval and launch by the end of 2020.
Kala resubmitted the NDA in response to the complete response letter (CRL) that it received from the FDA on Aug. 8, 2019, which indicated that positive data from an additional clinical trial was needed to demonstrate efficacy and to support a resubmission of the NDA.
CooperVision Names First Best Practices Student Scholarship Recipients
Following the announcement of its 2020 Best Practices honorees in April, CooperVision, Inc. has revealed the recipients of its new Best Practices Scholarship. Recipients were third-year optometry students who were chosen based on their academic standing at a U.S. optometry school; their demonstration of leadership and participation in school or community activities; honors; and additional optometry-related experience. The Best Practices Scholarship provides them with the opportunity to attend the 2020 Best Practices Summit, where they will listen to and collaborate with eyecare professionals from this year’s honored practices.
The inaugural Best Practices Scholarship recipients are Matthew Barnes, New England College of Optometry; Christina Cherny, SUNY College of Optometry; and Matthew Howell, Chicago College of Optometry.
Robert Geula, OD, New York
This patient is a high –26D myope. He was raised in a third-world country and had mesh sewn into his sclera to try to limit his myopia progression in his teens.
We thank Dr. Guela for this image and welcome photo submissions from our other readers! It is easy to submit a photo for consideration for publishing in Contact Lenses Today. Simply visit http://www.cltoday.com/upload/upload.aspx to upload your image. Please include a detailed explanation of the photo and your full name, degree or title, and city/state/country.
SPECIALTY LENS SPACE
Karen DeLoss, OD
Put It in Reverse
The power of reverse geometry lenses has more than one meaning: literally dioptric power but also a tool that specialty lens fitters can utilize to help their patients obtain their goal of both vision and comfort. Reverse geometry lenses are usually thought of as corneal GP lenses, but you can also consider reverse geometry in terms of hybrids and sclerals; although, some may argue that this does not fit into classic nomenclature.
Reverse geometry lenses classically have a flatter central base curve compared to the adjacent curvature.1 Normally, this type of design is used for eyes that are post-refractive surgery, post-corneal transplant, or other post-surgery and that have a flat center. I have also found these lenses to be helpful for many patients who have corneal scars. With scleral oblate designs, as well as reverse geometry hybrid designs, they typically have a flatter base curve. While these types of lenses are helpful for classic indications, the flat base curve can help improve vision in some cases. Alternately, they can be used as a way to reduce center thickness for patients who require a high-plus dioptric power. Finally, a reverse geometry lens can also help improve the corneal vault relationship to help combat excessive vaulting situations.2
Another popular use of reverse geometry is for myopia control, but I will save that discussion for next time.
1. Lim L, Siow KL, Sakamoto R, Chong JS, Tan DT. Reverse geometry contact lens wear after photorefractive keratectomy, radial keratotomy, or penetrating keratoplasty. Cornea. 2000 May;19:320-324.
2. DeNaeyer G. Utilizing Reverse Geometry to Improve Prolate And Oblate Fits. Contact Lens Spectrum. May 1, 2016 May;31:47.
MATERIALS & DESIGNS
David L. Kading, OD
Contact Lenses Would Work Great for You
You want to grow your contact lens practice? Well, the title of this column is guaranteed to grow your practice by at least 15%.* Some patients have been told that they can’t wear lenses because they have presbyopia, astigmatism, too high of a prescription, too low of a prescription, eye dryness, or a host of other reasons. Some of them prefer wearing glasses, but they might just have times—whether once a week or once a month—that they would prefer to be glasses-free.
We have options, our patients just may not be aware of them. And they will never know unless their provider brings it up to them. Contact lenses are economical in a daily modality, and they give both patients and practitioners what they desire.
Here is my challenge: When you start seeing patients regularly again for routine visits, say the following to every patient who is not already a lens wearer: “Have you ever considered wearing contact lenses? You would be an excellent candidate.” Your conversion rate will most certainly go up.
*There is no money-back guarantee, sorry.
Prospective 3-Arm Study on Pain and Epithelial Healing After Corneal Crosslinking
The purpose of this prospective cohort study was to investigate the effect of three regimens on pain and wound healing after corneal crosslinking (CXL).
Consecutive progressive keratoconus patients who underwent 9 mW/cm2 epithelium-off CXL were included. Patients received a bandage contact lens (n = 20), occlusive patch (n = 20), or antibiotic ointment (n = 20) after treatment. Pain scores and quality of life, measured by the McGill Pain Questionnaire and Visual Analogue Scale (VAS), were analyzed. Epithelial healing after two days, correlations between pain and psychological factors that influence pain perception (depression anxiety stress score and pain catastrophizing score), and oral pain medication were evaluated.
In the study, 60 eyes of 52 patients were analyzed. On average, patients experienced considerable pain after CXL (median VAS score 6.2, range 0 to 10). The postoperative regimen did not significantly affect pain scores, although the antibiotic ointment group reported a higher VAS score (median VAS score 7.2 versus 6.7 and 6.0; P = 0.57). Occlusive patching showed a trend to quicker resolution of epithelial defects (85% completely healed versus 65% with lenses and 70% with antibiotic ointment; P = 0.43). Correlations with pain-modulating psychological factors were weak (R < 0.3) and not significant. The use of pain medication corresponded poorly to the prescribed use.
This study demonstrated clinical equivalence of three regimens in combating postoperative pain after routine CXL. Wound healing appeared quicker in the occlusive patch group and, therefore, might be the best standard of care after CXL. The clinical tradition of using bandage contact lenses should be reevaluated.
Soeters N, Hendriks I, Godefrooij DA, Mensink MO, Wisse RPL. Prospective 3-arm study on pain and epithelial healing after corneal crosslinking. J Cataract Refract Surg. 2020 Jan;46(1):72-77.